Top 4 Insights from @PTarantinoMD’s Talk 👇 🎥 Full recording of his talk is now available on MD Academy: https://t.co/3oGAHXyYcn Exploring how ADCs are redefining what's possible in breast cancer care — Paolo Tarantino, MD of Dana-Farber Cancer Institute shared

Thank you @_MDEducation @Ryan_Fitzpatric @Daver_Leukemia @charliecraddock Elie Jabbour and @cpapayannidis for the opportunity to participate in this fantastic #leusm #hematology meeting and learn from our brilliant leukemia friends and colleagues!

The Inaugural NO LyMIT US Focus Meeting 2025 closed with a look ahead to the future of lymphoma microenvironment research and immune therapy innovation. 👏🏻 See the full sessions and expert insights on demand: https://t.co/ZzndHPijzx Experts from leading centers including UT

Two sides. One question. Today’s debate at the AML–ALL EU Focus Meeting 2025: Allo-mandatory adults with MRD+ CR1 AML — Should they proceed directly to transplant? 🎤 For: @charliecraddock | Felicitas Thol, MD Against: Stéphane de Botton, MD | @drpramilak Watch the full debate

The second day of the Inaugural NO LyMIT: Lymphoma Microenvironment & Immune Therapies US Focus Meeting 2025 is underway with Session: Challenges for Cell and Immune Therapies, moderated by Mark Hamilton, MD. Catch the full discussions on demand: https://t.co/ZzndHPijzx This

Today’s first session at the 4th Annual AML–ALL EU Focus Meeting 2025 featured @sanamloghavi, MD (MD Anderson Cancer Center, Houston, TX) presenting “Updates in AML Classification Systems and Incorporating Molecular Information into Optimizing Future Classification Systems to

Day 1 of the Inaugural NO LyMIT US Focus Meeting 2025 in New Orleans highlighted the lymphoma microenvironment and emerging immune therapies. Register to watch the full sessions on demand: https://t.co/ZzndHPijzx Presentations included: ▪️@AkilMerchantMD – Spatial Organization

Outstanding meeting with great science, great discussions, and a great time with colleagues and friends. @_MDEducation #acuteleukemia #leukemiaresearch #leukemia

A lot of fun to be in Athens for this great meeting! #hematology #leukemia #oncology

Outstanding presentations and great discussion at this excellent meeting.

Yesterday’s closing session of the 4th Annual AML–ALL EU Focus Meeting 2025 brought together experts to discuss the latest advances in first-line therapy for Ph-negative ALL, with insights across different age groups. Featuring: • Nicolas Boissel, MD – Adolescents & Young

We’ve just kicked off the Inaugural NO LyMIT: Lymphoma Microenvironment & Immune Therapies US Focus Meeting 2025 in New Orleans 🇺🇸 📽 Sign up to access post-meeting recordings: https://t.co/ZzndHPijzx Co-chaired by @ChrisRFlowersMD and Michael Green, PhD, today’s sessions

More highlights from Day 1 of the AML-ALL EU Focus Meeting 2025 in Athens. Sign up to watch the full meeting recording: https://t.co/YJQzX5NdQY #Hematology #Oncology #AML #ALL #Leukemia @Daver_Leukemia @sanamloghavi @charliecraddock @cpapayannidis

Snapshots from a dynamic opening day at the AML-ALL EU Focus Meeting 2025 in Athens, where leading experts and future innovations meet. 👏🏻 Sign up to watch the full meeting recording: https://t.co/YJQzX5MG1q Each session reflected one shared goal: improving lives through

Day 1 of the 4th Annual AML-ALL EU Focus Meeting 2025 is officially underway in Athens 🇬🇷 Join the waitlist for meeting recordings here: https://t.co/YJQzX5MG1q Co-chaired by Drs. @Daver_Leukemia, @cpapayannidis, Elias Jabbour, MD, and @charliecraddock, today’s agenda explores

PRRT, TKIs, or early systemic therapies — which strategies are shaping the future of NET care? 🎥 Watch the full session for free: https://t.co/dkc6Ixcnl3 Hear expert insights in the Neuroendocrine Tumors (NET) session from the Inaugural GI Cancers US Focus Meeting 2025 with

“I sure recommend attending this conference next year.” – Daniela Pugliese, MD Be part of the 3rd Annual Women In IBD EU Focus Meeting 2025. Join colleagues from across Europe for expert-led sessions, interactive panels, and networking events focused on advancing IBD research,

“The topics were perfectly chosen, and I really enjoyed listening to all of the talks.” – @TaniaJain11, Johns Hopkins University That’s what makes the MPN-MDS US Focus Meeting special, with a program and faculty carefully selected to create a forum where leading hematology

Breast Cancer Awareness Month is here 🎗️ Each year, millions of people are affected by breast cancer, making awareness, early detection, and access to effective treatments more critical than ever. Our mission is to empower healthcare professionals with the latest research,

New Orleans is calling 🇺🇸 The inaugural NO LyMIT: Lymphoma Microenvironment & Immune Therapies US Focus Meeting 2025 is almost here. Join leading experts for two days of cutting-edge discussions on immune therapies and lymphoma microenvironment research. Chairs: ▪️

Join leading lung cancer experts at the Inaugural Lung Cancer US Focus Meeting 2026 in Nashville to explore the latest clinical advancements and research breakthroughs. 🫁 Reserve your seat or sign up to access recordings: https://t.co/JBsomoarHY Co-chaired by @CharuAggarwalMD